MedPath

A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine

Phase 2
Completed
Conditions
Pain
Interventions
Drug: JNJ-10450232 / Not yet marketed
Registration Number
NCT02209181
Lead Sponsor
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Brief Summary

To assess the safety and effectiveness one dose of a new pain reliever medicine (JNJ-10450232 at either the 250 or 1000 mg strength) compared with placebo (sugar pill) or acetaminophen 1000 mg after surgical removal of third molars. The primary endpoint will evaluate pain relief effectiveness up to 6 hours after administration of the study drug.

Detailed Description

This is a single-center, randomized, double-blind, placebo- and active-controlled, parallel group study to evaluate the efficacy, safety and pharmacokinetic profile of JNJ-10450232, administered as a single dose in capsules (250 or 1000 mg), over a 24 hour period after molar extractions. Subjects will stay at the research center for \~24 hours after administration of study drug. Healthy male subjects, ages 18 to 45 years inclusive, will be screened by medical history, vital signs, an electrocardiogram (ECG), and clinical laboratory tests. Eligible subjects will return to the clinic on the day of surgery and complete baseline vital signs and clinical laboratory tests. They will undergo dental extraction of a minimum of three third-molars and, if qualified, will be randomly assigned to one of four study treatments for pain.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
269
Inclusion Criteria
  • Subjects aged 18-45 years
  • At least moderate dental pain assessed by a categorical scale pain intensity scale and a score of at least 5 on the 11-point (0-10) pain intensity numerical rating scale (PI-NRS) following surgical removal of three third-molars
Exclusion Criteria
  • Subjects who are not otherwise healthy
  • Test positive for the urine drug screen
  • Taking prohibited medications will not be allowed to participate in this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
JNJ-10450232 250 mgJNJ-10450232 / Not yet marketed-
JNJ-10450232 1000 mgJNJ-10450232 / Not yet marketed-
PlaceboJNJ-10450232 / Not yet marketed-
Acetaminophen 1000 mgacetaminophen / Tylenol-
Primary Outcome Measures
NameTimeMethod
Analgesic Efficacy From 0 to 6 Hours After the Dose Using the Time-weighted Sum of Pain Intensity Difference (SPID 0-6)6 Hours

Time-weighted sum of pain intensity difference by first multiplying each pain intensity difference (PID) score by the time from the previous time point, and adding them together for each scheduled time point within 0-6 hours. Time points included 15 minutes, 30 minutes, 45 minutes, 1 hour, 1.5 hours, 2 hours, 3 hours, 4 hours, 5 hours, and 6 hours. The minimum SPID 0-6 was -30 and the maximum SPID 0-6 was 60, where higher is better. Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain).

Secondary Outcome Measures
NameTimeMethod
Pain Relief (PAR) Scores at 4 Hours Post Dose4 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Intensity Difference From Baseline (PID) Scores at 15 Minutes Post DoseBaseline to 15 minutes post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 1 Hour Post DoseBaseline to 1 hour post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 1.5 Hours Post DoseBaseline to 1.5 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 2 Hours Post DoseBaseline to 2 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 3 Hours Post DoseBaseline to 3 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 30 Minutes Post DoseBaseline to 30 minutes post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 45 Minutes Post DoseBaseline to 45 minutes post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 4 Hours Post DoseBaseline to 4 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 5 Hours Post DoseBaseline to 5 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 6 Hours Post DoseBaseline to 6 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 7 Hours Post DoseBaseline to 7 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 8 Hours Post DoseBaseline to 8 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 9 Hours Post DoseBaseline to 9 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 10 Hours Post DoseBaseline to 10 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 11 Hours Post DoseBaseline to 11 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 12 Hours Post DoseBaseline to 12 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 16 Hours Post DoseBaseline to 16 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Intensity Difference From Baseline (PID) Scores at 24 Hours Post DoseBaseline to 24 hours post dose

Pain intensity is the amount of pain experienced on a scale of 1-10 (where 1=no pain and 10=very severe pain). The PID will be derived by subtracting the pain intensity from the baseline pain intensity.

Pain Relief (PAR) Scores at 15 Minutes Post Dose15 minutes post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 30 Minutes Post Dose30 minutes post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 45 Minutes Post Dose45 minutes post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 1 Hour Post Dose1 hour post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 1.5 Hours Post Dose1.5 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 2 Hours Post Dose2 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 3 Hours Post Dose3 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 5 Hours Post Dose5 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 6 Hours Post Dose6 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 7 Hours Post Dose7 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 8 Hours Post Dose8 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 9 Hours Post Dose9 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 10 Hours Post Dose10 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 11 Hours Post Dose11 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 12 Hours Post Dose12 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 16 Hours Post Dose16 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Pain Relief (PAR) Scores at 24 Hours Post Dose24 hours post dose

Pain relief is the amount of pain relief on a scale of 1-10 (where 1=no relief and 10=complete relief).

Duration of Pain Relief After Dosing (Time to Rescue Medication)Completed at time of the first rescue medication (hours post dose), estimated up through Day 2

Time (minutes) to rescue medication was measured as the elapsed time from when the investigational product was given until the time rescue medication was given.

Subject Global EvaluationCompleted at hour 12 or at time of the first rescue medication (hours post dose).

How the subject would rate the study medication as a pain-reliever on a scale of 0-4 (where 0=poor and 4=excellent).

Trial Locations

Locations (1)

Jean Brown Research

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath